Editorial

PCR London Valves – in person or online – an invaluable opportunity for exchange dedicated to advancing the treatment of valvular heart disease

EuroIntervention 2023;19:705-706. DOI: 10.4244/EIJ-E-23-00050

Francesco Maisano
Francesco Maisano1, MD; Nicolo Piazza2, MD, PhD; Bernard Prendergast3, PhD, DM; Simon Redwood3, MD; Didier Tchétché4, MD, PhD; Nina C. Wunderlich5, MD; PCR London Valves 2023 Course Directors
1. Cardio-Thoracic-Vascular Department, IRCCS San Raffaele Scientific Institute, Milan, Italy; 2. Department of Medicine, Division of Cardiology, McGill University Health Center, Montreal, Canada; 3. Department of Cardiology, St Thomas’ Hospital and Cleveland Clinic, London, United Kingdom; 4. Groupe CardioVasculaire Interventionnel, Clinique Pasteur, Toulouse, France; 5. Asklepios Klinik Langen, Langen, Germany
Over the last 15 years, PCR London Valves has established its reputation as one of the key international gatherings for all those interested in the treatment of valvular heart disease. The Course is now a key point in the annual calendar when the community unites to share experiences and learn about the latest developments that are the hallmark of our rapidly evolving field.

PCR London Valves remains resolutely international and has long been committed to global diversity, exemplified in this year’s edition which will include a vast mix of participants from around the world. With year-on-year growth in ...

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Patient-prosthesis mismatch following TAVR: time will tell

Latest news